This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Meda Pharmaceuticals Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Harry J Sacks: Innovator in Pharmaceutical Compositions
Introduction
Harry J Sacks is a notable inventor based in New Brunswick, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that include carisoprodol, a skeletal muscle relaxant. His work aims to improve the treatment of musculoskeletal pain and muscle spasms.
Latest Patents
Sacks holds a patent for "Compositions comprising carisoprodol and methods of use thereof." This invention provides pharmaceutical compositions that include carisoprodol or its pharmaceutically acceptable salts, esters, or derivatives. The patent outlines methods for using these compositions to prevent, alleviate, and treat various painful conditions while minimizing the somnolence often associated with muscle relaxants.
Career Highlights
Harry J Sacks has been instrumental in advancing pharmaceutical formulations at Meda Pharmaceuticals Inc. His innovative approach to combining carisoprodol with additional active agents, such as nonsteroidal anti-inflammatory drugs (NSAIDs), showcases his commitment to enhancing patient care. With 1 patent to his name, Sacks continues to influence the pharmaceutical industry.
Collaborations
Sacks has worked alongside talented colleagues, including Benjamin Johns and Gul Balwani. Their collaborative efforts contribute to the ongoing development of effective pharmaceutical solutions.
Conclusion
Harry J Sacks is a dedicated inventor whose work in pharmaceutical compositions has the potential to significantly improve the treatment of musculoskeletal conditions. His innovative contributions continue to shape the future of pain management.